Search research articles
Contact Us
Filters
Showing results (411-420 of 504) with videos related to
Page
of 51
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 26, 2026
Prognostic Value of Early Follow-Up PSMA PET/CT After 2 Cycles of [<sup>177</sup>Lu]Lu-PSMA RPT in Patients with mCRPC: Comparison with PSA Dynamics
Liam Widjaja, Johannes Hornfeck, Sophie C Siegmund, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 30, 2020
High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT
Rudolf A Werner, Thorsten Derlin, Steven P Rowe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 30, 2021
The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
Liang Dong, Yun Su, Yinjie Zhu, et al.
Cancers
|
January 21, 2022
Changing Threshold-Based Segmentation Has No Relevant Impact on Semi-Quantification in the Context of Structured Reporting for PSMA-PET/CT
Patrick W Mihatsch, Matthias Beissert, Martin G Pomper, et al.
Science Advances
|
July 9, 2019
Imaging CAR T cell therapy with PSMA-targeted positron emission tomography
Il Minn, David J Huss, Hye-Hyun Ahn, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 5, 2023
SUV
Philipp E Hartrampf, Thomas Hüttmann, Anna Katharina Seitz, et al.
Molecular Oncology
|
August 17, 2018
From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real-world setting
Steven P Rowe, Brandon Luber, Monique Makell, et al.
Advances in Radiation Oncology
|
April 14, 2020
Online Prostate-Specific Membrane Antigen and Positron Emission Tomography-Guided Radiation Therapy for Oligometastatic Prostate Cancer
William T Hrinivich, Ryan Phillips, Angela J Da Silva, et al.
The Journal of Urology
|
October 18, 2024
Clinical Factors Associated With Suspicious <sup>18</sup>F-DCFPyL Prostate-Specific Membrane Antigen Positron Emission Tomography Activity in Patients Initially Managed With Radical Prostatectomy Including Prostate-Specific Antigen < 0.5 ng/mL
Eric V Li, Richard Bennett, Austin Ho, et al.
Molecular Imaging and Biology
|
July 30, 2024
Imaging of Chromophobe Renal Cell Carcinoma with <sup>99m</sup>Tc-Sestamibi SPECT/CT: Considerations Regarding Risk Stratification and Histologic Reclassification
Steven P Rowe, Salikh Murtazaliev, Jorge D Oldan, et al.
Page
of 51
Search research articles
Search
Showing results (411-420 of 504) with videos related to
Sort By:
Page
of 51
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 26, 2026
Prognostic Value of Early Follow-Up PSMA PET/CT After 2 Cycles of [<sup>177</sup>Lu]Lu-PSMA RPT in Patients with mCRPC: Comparison with PSA Dynamics
Liam Widjaja, Johannes Hornfeck, Sophie C Siegmund, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 30, 2020
High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT
Rudolf A Werner, Thorsten Derlin, Steven P Rowe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 30, 2021
The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
Liang Dong, Yun Su, Yinjie Zhu, et al.
Cancers
|
January 21, 2022
Changing Threshold-Based Segmentation Has No Relevant Impact on Semi-Quantification in the Context of Structured Reporting for PSMA-PET/CT
Patrick W Mihatsch, Matthias Beissert, Martin G Pomper, et al.
Science Advances
|
July 9, 2019
Imaging CAR T cell therapy with PSMA-targeted positron emission tomography
Il Minn, David J Huss, Hye-Hyun Ahn, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 5, 2023
SUV
Philipp E Hartrampf, Thomas Hüttmann, Anna Katharina Seitz, et al.
Molecular Oncology
|
August 17, 2018
From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real-world setting
Steven P Rowe, Brandon Luber, Monique Makell, et al.
Advances in Radiation Oncology
|
April 14, 2020
Online Prostate-Specific Membrane Antigen and Positron Emission Tomography-Guided Radiation Therapy for Oligometastatic Prostate Cancer
William T Hrinivich, Ryan Phillips, Angela J Da Silva, et al.
The Journal of Urology
|
October 18, 2024
Clinical Factors Associated With Suspicious <sup>18</sup>F-DCFPyL Prostate-Specific Membrane Antigen Positron Emission Tomography Activity in Patients Initially Managed With Radical Prostatectomy Including Prostate-Specific Antigen < 0.5 ng/mL
Eric V Li, Richard Bennett, Austin Ho, et al.
Molecular Imaging and Biology
|
July 30, 2024
Imaging of Chromophobe Renal Cell Carcinoma with <sup>99m</sup>Tc-Sestamibi SPECT/CT: Considerations Regarding Risk Stratification and Histologic Reclassification
Steven P Rowe, Salikh Murtazaliev, Jorge D Oldan, et al.
Page
of 51